FAM75A6 Inhibitors
The chemical class of FAM75A6 Inhibitors encompasses a diverse range of compounds that can potentially inhibit the activity of the FAM75A6 protein, either directly or indirectly. FAM75A6 is likely involved in cellular processes regulated by signaling pathways such as MAPK, AMPK, proteasome, calcium signaling, and others.
Direct inhibitors such as curcumin, bortezomib, metformin, resveratrol, SB202190, dexamethasone, thapsigargin, cisplatin, auranofin, rapamycin, PD0325901, and celecoxib can target specific kinases, enzymes, or signaling molecules involved in these pathways, potentially disrupting cellular processes that rely on FAM75A6 function. Indirect inhibitors exert their effects by modulating cellular responses and signaling cascades that intersect with FAM75A6-mediated pathways, ultimately influencing the activity of FAM75A6. These inhibitors provide valuable tools for investigating the physiological roles of FAM75A6 and may have implications in diseases where dysregulation of FAM75A6-associated pathways occurs.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin is a natural compound found in turmeric that has been studied for its anti-inflammatory and antioxidant properties. It can inhibit various signaling pathways, potentially influencing cellular processes regulated by FAM75A6. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is a proteasome inhibitor used in cancer therapy. It blocks the activity of the proteasome, leading to the accumulation of misfolded proteins and apoptosis. Inhibition of proteasome function by bortezomib may indirectly affect FAM75A6-mediated processes. | ||||||
Metformin | 657-24-9 | sc-507370 | 10 mg | $79.00 | 2 | |
Metformin is an antidiabetic drug that activates AMP-activated protein kinase (AMPK), a key regulator of cellular energy metabolism. Activation of AMPK by metformin can modulate cellular processes, potentially influencing the activity of FAM75A6. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol is a polyphenolic compound found in grapes and red wine. It has been shown to have antioxidant and anti-inflammatory properties. Resveratrol can modulate various signaling pathways, potentially affecting cellular processes regulated by FAM75A6. | ||||||
PD 169316 | 152121-53-4 | sc-204168 sc-204168A sc-204168B sc-204168C | 1 mg 5 mg 10 mg 25 mg | $88.00 $156.00 $281.00 $461.00 | 3 | |
SB202190 is a selective inhibitor of p38 mitogen-activated protein kinase (MAPK). It can block p38 MAPK signaling, which is involved in stress responses and inflammation. Inhibition of p38 MAPK by SB202190 may indirectly affect FAM75A6-mediated processes. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone can modulate gene expression and inhibit inflammatory signaling pathways, potentially influencing cellular processes regulated by FAM75A6. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a potent inhibitor of the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA) pump, leading to calcium dysregulation and endoplasmic reticulum stress. Disruption of calcium homeostasis by thapsigargin may indirectly affect FAM75A6-mediated processes. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin forms DNA adducts, leading to DNA damage and apoptosis. Its cytotoxic effects may indirectly influence cellular processes regulated by FAM75A6. | ||||||
Auranofin | 34031-32-8 | sc-202476 sc-202476A sc-202476B | 25 mg 100 mg 2 g | $153.00 $214.00 $4000.00 | 39 | |
Auranofin can inhibit thioredoxin reductase, leading to oxidative stress and modulation of redox signaling pathways. These effects may indirectly impact FAM75A6-mediated processes. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is a macrolide antibiotic that inhibits the activity of mammalian target of rapamycin (mTOR), a kinase involved in cellular growth and proliferation pathways. Inhibition of mTOR by rapamycin can disrupt downstream signaling cascades, potentially affecting cellular processes regulated by FAM75A6. | ||||||